Home > Search Results

Results: 3

Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum

Evidence from randomised controlled trials (RCTs) to establish the beneficial and harmful effects of drugs altering blood clotting for treating disseminated intravascular coagulation (DIC) in pregnant women and following birth is lacking.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2012

Drug therapy for treating systemic intravascular activation of coagulation in patients with leukemia

We reviewed the clinical benefits and harms of anticoagulant and antifibrinolytic therapy for treating disseminated intravascular coagulation (DIC) in patients with acute or chronic leukemia.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2015

Antifibrinolytics (tranexamic acid and epsilon‐aminocaproic acid) to prevent bleeding in patients with low platelets due to bone marrow failure

Patients with haematological (blood) cancers and other blood disorders are frequently at risk of severe or life‐threatening bleeding from having low platelets (thrombocytopenia). This may be from bone marrow failure due to an underlying blood disorder but also from the toxic effect of treatment (chemotherapy) on the bone marrow. Such patients can be given prophylactic platelet transfusions (from donations) to prevent bleeding if their own platelet counts are too low. These transfusions are not without risks, ranging from mild reactions like fevers to more serious, or even life‐threatening, consequences such as infections transmitted to the patient from the transfused platelets, despite stringent attempts to prevent this.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2013

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...